Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of
the current management of chronic obstructive pulmonary disease (COPD) and are critical in …

Predictors of asthma control: what can we modify? : Current Opinion in Allergy and Clinical
Immunology Predictors of asthma control: what can we modify? : Current Opinion in Allergy and …

Бронхиальная астма-одно из наиболее распространённых заболеваний дыхательных
путей (около 7% взрослых и 10% подростков и детей страдают бронхиальной астмой в …

Background Safety concerns regarding long-acting β2-agonists (LABAs) in asthma
management were initially identified in a large postmarketing trial in which the risk of death …

Аннотация Бронхиальная астма (БА) является гетерогенным заболеванием, при
котором требуется выделение различных фенотипов и персонифицированный подход …

Background Current recommendations for managing persistent asthma during pregnancy
when low-dose inhaled corticosteroids (ICSs) are insufficient include adding a long-acting β …

Severe asthma is considered a heterogeneous disease in which a variety of clinical,
physiological and inflammatory markers determine disease severity. Pivotal studies in the …

Introduction Asthma is one of the most common chronic diseases in Germany. Substantial
economic evaluation of asthma cost requires knowledge of asthma severity, which is in …

Purpose There is conflicting evidence regarding the association between montelukast and
neuropsychiatric events (NE). We sought to examine this association among children with …

Multifactorial assessments, including comorbidities, treatment adherence, and
polypharmacy, are important for better asthma control in elderly asthmatic patients. Further …